| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 35 |
| 1 | TACROLIMUS | 35 |
| 2 | PREDNISOLONE | 33 |
| 3 | PREDNISOLONE ORAL | 33 |
| 4 | PREDNISOLONE ORAL SOLUTION | 33 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 33 |
| 6 | TACROLIMUS OINTMENT 0.1% | 33 |
| 7 | ADALIMUMAB | 30 |
| 8 | MYCOPHENOLATE MOFETIL | 29 |
| 9 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEFLAZACORT | 7 | 0.0027 |
| 1 | ISONIAZID | 15 | 0.0009 |
| 2 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| 3 | PYRAZINAMIDE | 7 | 0.0007 |
| 4 | RIFABUTIN | 2 | 0.0007 |
| 5 | CILOSTAZOL | 3 | 0.0005 |
| 6 | GOLIMUMAB | 6 | 0.0005 |
| 7 | MARIBAVIR | 1 | 0.0004 |
| 8 | ETHAMBUTOL HYDROCHLORIDE | 1 | 0.0004 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 3 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 60 |
| 1 | Corticosteroid [EPC] | 59 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 21 |
| 3 | Antimycobacterial [EPC] | 15 |
| 4 | Purine Antimetabolite [EPC] | 7 |
| 5 | Integrin Receptor Antagonist [EPC] | 6 |
| 6 | Kinase Inhibitor [EPC] | 6 |
| 7 | Vitamin B12 [EPC] | 6 |
| 8 | Vitamin C [EPC] | 6 |
| 9 | Vitamin D [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimycobacterial [EPC] | 15 | 0.0006 |
| 1 | Rifamycin Antimycobacterial [EPC] | 2 | 0.0006 |
| 2 | Phosphodiesterase 3 Inhibitor [EPC] | 3 | 0.0005 |
| 3 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 5 | Rifamycin Antibacterial [EPC] | 4 | 0.0001 |
| 6 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 3 | 0.0001 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 8 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |
| 9 | Central alpha-2 Adrenergic Agonist [EPC] | 4 | 0.0001 |